| Members |
associationTargetComponent |
| pT2a: Tumour invades superficial muscle (inner half) (urinary bladder) |
pT2a |
| pT2a: Tumour more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis or greater than 2 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
pT2a |
| pT2a: Tumour more than 5 cm in greatest dimension, superficial tumour (extraosseous primitive neuroectodermal tumour/Ewing's sarcoma) |
pT2a |
| pT2a: Tumour more than 5 cm in greatest dimension, superficial tumour (soft tissue) |
pT2a |
| pT2a: Unilateral, one-half of one lobe or less (prostate) |
pT2a |
| pT2b (IIB): Extension to AND/OR implants on other pelvic tissues. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) |
pT2b |
| pT2b (IIB): Invasion of the stromal connective tissue of the cervix (TNM category and FIGO stage) (corpus uteri) |
pT2b |
| pT2b (IIB): Tumour involves one or both fallopian tubes with extension to other pelvic structures (TNM category and FIGO stage) (fallopian tube) |
pT2b |
| pT2b (IIB): Tumour with parametrial invasion (TNM category and FIGO stage) (uterine cervix) |
pT2b |
| pT2b category |
pT2b |
| pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration (melanoma of the skin) |
pT2b |
| pT2b: Tumour 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) |
pT2b |
| pT2b: Tumour extends to the soft tissues of the oropharnyx and/or nasal cavity with parapharyngeal extension (nasopharynx) |
pT2b |
| pT2b: Tumour invades choroid focally (retinoblastoma) |
pT2b |
| pT2b: Tumour invades deep muscle (outer half) (urinary bladder) |
pT2b |
| pT2b: Tumour invades subserosa (stomach) |
pT2b |
| pT2b: Tumour more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
pT2b |
| pT2b: Tumour more than 5 cm in greatest dimension, deep tumour (extraosseous primitive neuroectodermal tumour/Ewing's sarcoma) |
pT2b |
| pT2b: Tumour more than 5 cm in greatest dimension, deep tumour (soft tissue) |
pT2b |
| pT2b: Unilateral, involving more than one-half of lobe but not both lobes (prostate) |
pT2b |
| pT2c (IIC): Pelvic extension AND/OR implants (T2a or T2b/IIA or IIB) with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) |
pT2c |
| pT2c (IIC): Tumour involves one or both fallopian tubes with pelvic extension with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube) |
pT2c |
| pT2c category |
pT2c |
| pT2c: Bilateral disease (prostate) |
pT2c |
| pT2c: Tumour 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma) |
pT2c |
| pT2c: Tumour invades optic nerve up to, but not through, the level of the lamina cribrosa and invades the choroid focally (retinoblastoma) |
pT2c |
| pT2c: Tumour more than 2 cm, but not more than 5 cm, in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
pT2c |
| pT3 (III): Local and/or regional spread as specified in pT3a, pT3b, pN1, and FIGO IIIA, IIIB, and IIIC (TNM category and FIGO stage) (corpus uteri) |
pT3 |
| pT3 (III): Tumour extends to pelvic wall (TNM category and FIGO stage) (vagina) |
pT3 |
| pT3 (III): Tumour extends to pelvic wall and/or involves lower third of vagina and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix) |
pT3 |
| pT3 (III): Tumour involves one or both fallopian tubes, with peritoneal implants outside the pelvis (TNM category and FIGO stage) (fallopian tube) |
pT3 |
| pT3 (III): Tumour of any size with contiguous spread to the lower urethra and/or vagina or anus (TNM category and FIGO stage) (vulva) |
pT3 |
| pT3 and/or N1 (III): Tumour involves one or both fallopian tubes, with peritoneal implants outside the pelvis AND/OR regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube) |
pT3 |
| pT3 and/or N1 (III): Tumour involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis (including liver capsule metastasis) and/or regional lymph node metastasis (TNM category and FIGO stage) (ovary) |
pT3 |
| pT3 category |
pT3 |
| pT3: Discontinuous tumours in the primary bone site (bone) |
pT3 |
| pT3: Discontinuous tumours in the primary bone site (osseous primitive neuroectodermal tumour/Ewing's sarcoma) |
pT3 |
| pT3: Extraprostatic extension (prostate) |
pT3 |
| pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration (melanoma of the skin) |
pT3 |
| pT3: Multiple tumours more than 5 cm or tumour involving a major branch of the portal or hepatic vein(s) (liver, including intrahepatic bile ducts) |
pT3 |
| pT3: Significant invasion of the optic nerve and/or optic coats (retinoblastoma) |
pT3 |
| pT3: Tumour confluent with or extending into the ciliary body and/or choroid with scleral extension (iris) (uveal melanoma) |
pT3 |
| pT3: Tumour extends beyond the pancreas but without involvement of the coeliac axis or the superior mesenteric artery (exocrine pancreas) |
pT3 |
| pT3: Tumour extends into major veins or invades adrenal gland or perirenal and/or renal sinus fat but not beyond Gerota's fascia (kidney) |
pT3 |
| pT3: Tumour extends to invade the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate (nasal cavity and ethmoid sinus) |
pT3 |
| pT3: Tumour having extraparenchymal extension, and/or more than 4 cm but not more than 6 cm in greatest dimension, without seventh nerve involvement (major salivary glands) |
pT3 |
| pT3: Tumour invades adventitia (oesophagus) |
pT3 |
| pT3: Tumour invades any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, ethmoid sinuses (maxillary sinus) |
pT3 |
| pT3: Tumour invades beyond muscularis into peripelvic fat or renal parenchyma (renal pelvis) |
pT3 |
| pT3: Tumour invades beyond muscularis into periureteric fat (ureter) |
pT3 |
| pT3: Tumour invades beyond muscularis into periureteric fat or renal parenchyma (renal pelvis) |
pT3 |
| pT3: Tumour invades pancreas (ampulla of Vater) |
pT3 |
| pT3: Tumour invades perivesical tissue (urinary bladder) |
pT3 |
| pT3: Tumour invades the liver, gallbladder, pancreas, and/or ipsilateral branches of the portal vein (right or left) or hepatic artery (right or left) (extrahepatic bile ducts) |
pT3 |
| pT3: Tumour invades the spermatic cord with or without vascular/lymphatic invasion (testis) |
pT3 |
| pT3: Tumour invades through the muscularis propria into the subserosa or into mesoappendix (appendix) |
pT3 |
| pT3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues (colon/rectum) |
pT3 |
| pT3: Tumour invades through the muscularis propria into the subserosa or into the nonperitonealized perimuscular tissue (mesentery or retroperitoneum) with extension 2 cm or less (small intestine) |
pT3 |
| pT3: Tumour involves any of the ipsilateral pleural surfaces plus additional sites as by AJCC 6th Edition definition (thoracic mesothelioma) |
pT3 |
| pT3: Tumour involves bony structures and/or paranasal sinuses (nasopharynx) |
pT3 |
| pT3: Tumour limited to larynx with vocal cord fixation (larynx, subglottis) |
pT3 |
| pT3: Tumour limited to the larynx with vocal cord fixation and/or invades any of the following: postcrocoid area, pre-epiglottic tissues, paraglottic space, and/or minor thyroid cartilage erosion (e.g., inner cortex) (larynx, supraglottis) |
pT3 |
| pT3: Tumour limited to the larynx with vocal cord fixation, and/or invades the paraglottic space, and/or minor thyroid cartilage erosion (larynx, glottis) |
pT3 |
| pT3: Tumour measures more than 4 cm in greatest dimension or with fixation of hemilarynx (hypopharynx) |
pT3 |
| pT3: Tumour more than 16 mm in greatest diameter and/or greater than 10 mm in maximum height (thickness) without extraocular extension (ciliary body and choroid) (uveal melanoma) |
pT3 |
| pT3: Tumour more than 4 cm and/or tumour having extraparenchymal extension (major salivary glands) |
pT3 |
| pT3: Tumour more than 4 cm in greatest dimension (lip and oral cavity) |
pT3 |
| pT3: Tumour more than 4 cm in greatest dimension (oropharynx) |
pT3 |
| pT3: Tumour more than 4 cm in greatest dimension limited to the thyroid or any tumour with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues) (thyroid) |
pT3 |
| pT3: Tumour more than 5 cm in greatest dimension (anal canal) |
pT3 |
| pT3: Tumour more than 5 cm in greatest dimension (breast) |
pT3 |
| pT3: Tumor more than 5 cm in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
pT3 |
| pT3: Tumour penetrates serosa (visceral peritoneum) without invasion of adjacent structures (stomach) |
pT3 |
| pT3: Tumour perforates the serosa (visceral peritoneum) and/or directly invades the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts (gallbladder) |
pT3 |
| pT3:Tumour directly invades any of following:chest wall,diaphragm,mediastinal pleura,parietal pericardium;or tumour in main bronchus<2 cm distal to carina(not involving it);or assoc atelectasis or obstructive pneumonitis of whole lung |
pT3 |
| pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumour) (TNM category and FIGO stage) (ovary) |
pT3a |
| pT3a (IIIA): Tumour involves lower third of vagina, no extension to pelvic wall (TNM category and FIGO stage) (uterine cervix) |
pT3a |
| pT3a (IIIA): Tumour involves one or both fallopian tubes, with microscopic peritoneal metastasis outside the pelvis (TNM category and FIGO stage) (fallopian tube) |
pT3a |
| pT3a (IIIA): Tumour involves serosa, AND/OR adnexa (direct extension or metastasis) (TNM category and FIGO stage) (corpus uteri) |
pT3a |
| pT3a (IIIA): Tumour involves serosa, AND/OR adnexa (direct extension or metastasis) AND/OR cancer cells in ascites or peritoneal washings (TNM category and FIGO stage) (corpus uteri) |
pT3a |
| pT3a category |
pT3a |
| pT3a: Extraprostatic extension (prostate) |
pT3a |
| pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration (melanoma of the skin) |
pT3a |
| pT3a: Tumour confluent with or extending into the ciliary body and/or choroid with scleral extension and melanomalytic glaucoma (iris) (uveal melanoma) |
pT3a |
| pT3a: Tumour directly invades adrenal gland or perirenal and/or renal sinus fat but not beyond Gerota's fascia (kidney) |
pT3a |
| pT3a: Tumor invades optic nerve through the level of the lamina cribrosa but not to the line of resection (retinoblastoma) |
pT3a |
| pT3a: Tumour invades perivesical tissue microscopically (urinary bladder) |
pT3a |
| pT3a: Tumour more than 5 cm in greatest dimension, limited to dermis or not more than 2 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
pT3a |
| pT3b (IIIB): Involvement of vagina (direct extension or metastasis), rectal or bladder wall (without mucosal involvement), or pelvic wall(s) (frozen pelvis) (TNM category and FIGO stage) (corpus uteri) |
pT3b |
| pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension (TNM category and FIGO stage) (ovary) |
pT3b |
| pT3b (IIIB): Tumour extends to pelvic wall and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix) |
pT3b |
| pT3b (IIIB): Tumour involves one or both fallopian tubes, with macroscopic peritoneal metastasis outside the pelvis 2 cm or less in greatest dimension (TNM category and FIGO stage) (fallopian tube) |
pT3b |
| pT3b category |
pT3b |
| pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration (melanoma of the skin) |
pT3b |
| pT3b: Seminal vesicle invasion (prostate) |
pT3b |
| pT3b: Tumour grossly extends into the renal vein or its segmental (muscle-containing) branches, or vena cava below the diaphragm (kidney) |
pT3b |
| pT3b: Tumour invades perivesical tissue macroscopically (extravesical mass) (urinary bladder) |
pT3b |
| pT3b: Tumour massively invades the choroid (retinoblastoma) |
pT3b |
| pT3b: Tumour more than 5 cm in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
pT3b |
| pT3c (IIIC): Tumour involves one or both fallopian tubes, with peritoneal metastasis outside the pelvis more than 2 cm in diameter (TNM category and FIGO stage) (fallopian tube) |
pT3c |
| pT3c AND/OR N1 (IIIC): Peritoneal metastasis beyond pelvis more than 2 cm in greatest dimension AND/OR regional lymph node metastasis (TNM category and FIGO stage) (ovary) |
pT3c |
FHIR